Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bacterial Toxins | 60 | 2024 | 265 | 11.110 |
Why?
|
Bacterial Proteins | 30 | 2024 | 474 | 6.060 |
Why?
|
Bacillus anthracis | 30 | 2020 | 146 | 4.090 |
Why?
|
Antigens, Bacterial | 29 | 2021 | 159 | 3.900 |
Why?
|
Macrophages | 19 | 2018 | 274 | 2.600 |
Why?
|
Clostridium Infections | 13 | 2024 | 66 | 2.180 |
Why?
|
Gene Expression Regulation, Bacterial | 9 | 2024 | 152 | 1.750 |
Why?
|
Anthrax | 14 | 2020 | 85 | 1.660 |
Why?
|
Animals | 62 | 2024 | 9962 | 1.510 |
Why?
|
Antibodies, Neutralizing | 11 | 2021 | 69 | 1.400 |
Why?
|
Spores, Bacterial | 7 | 2022 | 45 | 1.370 |
Why?
|
Virulence Factors | 7 | 2021 | 45 | 1.350 |
Why?
|
Epitopes | 7 | 2020 | 171 | 1.340 |
Why?
|
Mice | 43 | 2024 | 4406 | 1.260 |
Why?
|
Enterotoxins | 4 | 2021 | 21 | 1.250 |
Why?
|
CHO Cells | 16 | 2020 | 96 | 1.150 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 3 | 2018 | 26 | 1.100 |
Why?
|
Glycogen Synthase Kinase 3 | 5 | 2011 | 31 | 1.070 |
Why?
|
Leukocytes | 2 | 2018 | 67 | 1.040 |
Why?
|
Repressor Proteins | 2 | 2019 | 114 | 1.020 |
Why?
|
Cell Line | 18 | 2018 | 672 | 1.010 |
Why?
|
Cytokines | 6 | 2018 | 439 | 0.930 |
Why?
|
Virulence | 11 | 2021 | 144 | 0.930 |
Why?
|
Cyclic AMP | 4 | 2018 | 80 | 0.920 |
Why?
|
Immunoglobulin G | 14 | 2024 | 266 | 0.870 |
Why?
|
Bacterial Vaccines | 2 | 2022 | 28 | 0.850 |
Why?
|
Enterocolitis, Pseudomembranous | 3 | 2015 | 12 | 0.850 |
Why?
|
Slipped Capital Femoral Epiphyses | 1 | 2022 | 1 | 0.840 |
Why?
|
Femur Head Necrosis | 1 | 2022 | 2 | 0.840 |
Why?
|
Cricetulus | 9 | 2020 | 56 | 0.840 |
Why?
|
Embryo, Nonmammalian | 3 | 2007 | 25 | 0.800 |
Why?
|
Clostridium | 6 | 2004 | 61 | 0.760 |
Why?
|
Receptors, Peptide | 5 | 2012 | 20 | 0.750 |
Why?
|
Peptide Fragments | 3 | 2017 | 197 | 0.710 |
Why?
|
B-Lymphocytes | 7 | 2024 | 276 | 0.700 |
Why?
|
Humans | 39 | 2024 | 26846 | 0.700 |
Why?
|
Immunity, Innate | 3 | 2022 | 205 | 0.660 |
Why?
|
Signal Transduction | 6 | 2020 | 1344 | 0.660 |
Why?
|
Antibodies, Bacterial | 8 | 2021 | 100 | 0.660 |
Why?
|
Natural Killer T-Cells | 5 | 2022 | 54 | 0.660 |
Why?
|
Cricetinae | 12 | 2016 | 129 | 0.650 |
Why?
|
HeLa Cells | 7 | 2023 | 206 | 0.640 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 25 | 0.630 |
Why?
|
Clostridium sordellii | 2 | 2009 | 2 | 0.610 |
Why?
|
Food Additives | 1 | 2018 | 2 | 0.600 |
Why?
|
Cell-Penetrating Peptides | 1 | 2017 | 6 | 0.590 |
Why?
|
Anthrax Vaccines | 7 | 2020 | 34 | 0.590 |
Why?
|
Amino Acid Sequence | 8 | 2024 | 674 | 0.560 |
Why?
|
Mice, Inbred BALB C | 9 | 2013 | 264 | 0.510 |
Why?
|
Peptidoglycan | 2 | 2013 | 47 | 0.510 |
Why?
|
Zebrafish | 5 | 2010 | 95 | 0.510 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 1999 | 30 | 0.490 |
Why?
|
Genes, Bacterial | 8 | 2008 | 106 | 0.480 |
Why?
|
Antigenic Variation | 1 | 2013 | 3 | 0.440 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2013 | 6 | 0.440 |
Why?
|
Receptor, Notch1 | 1 | 2013 | 25 | 0.430 |
Why?
|
Mice, Inbred C57BL | 17 | 2024 | 1475 | 0.430 |
Why?
|
Apoptosis | 3 | 2007 | 739 | 0.430 |
Why?
|
Cytotoxins | 2 | 2006 | 51 | 0.430 |
Why?
|
Mutation | 10 | 2021 | 820 | 0.410 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 627 | 0.410 |
Why?
|
Immunization | 8 | 2022 | 118 | 0.410 |
Why?
|
Protein Conformation | 3 | 2019 | 250 | 0.410 |
Why?
|
Monocytes | 1 | 2013 | 132 | 0.400 |
Why?
|
Hazardous Substances | 1 | 2011 | 6 | 0.390 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2011 | 13 | 0.380 |
Why?
|
Immunosuppressive Agents | 2 | 2011 | 140 | 0.370 |
Why?
|
Macrolides | 2 | 2001 | 18 | 0.370 |
Why?
|
Shock, Septic | 2 | 2013 | 38 | 0.360 |
Why?
|
Molecular Sequence Data | 8 | 2015 | 1036 | 0.360 |
Why?
|
Multiprotein Complexes | 1 | 2011 | 50 | 0.360 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 93 | 0.350 |
Why?
|
Cells, Cultured | 6 | 2013 | 970 | 0.350 |
Why?
|
Phenotype | 4 | 2021 | 667 | 0.340 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2009 | 38 | 0.340 |
Why?
|
Dendritic Cells | 1 | 2011 | 142 | 0.330 |
Why?
|
Glycosylation | 4 | 2019 | 69 | 0.310 |
Why?
|
Hydrogen-Ion Concentration | 6 | 2010 | 261 | 0.310 |
Why?
|
Heart | 2 | 2007 | 219 | 0.310 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2020 | 34 | 0.300 |
Why?
|
Cell Nucleus | 1 | 2008 | 135 | 0.300 |
Why?
|
Phosphorylation | 4 | 2011 | 560 | 0.300 |
Why?
|
Alanine | 1 | 2007 | 40 | 0.290 |
Why?
|
Immunologic Memory | 4 | 2024 | 58 | 0.290 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 1998 | 45 | 0.280 |
Why?
|
Caspases | 2 | 2007 | 43 | 0.280 |
Why?
|
Galactosylceramides | 4 | 2021 | 31 | 0.270 |
Why?
|
Adenylyl Cyclases | 1 | 2005 | 14 | 0.250 |
Why?
|
RNA, Messenger | 4 | 2023 | 646 | 0.250 |
Why?
|
Female | 21 | 2024 | 14466 | 0.240 |
Why?
|
Germinal Center | 1 | 2024 | 20 | 0.230 |
Why?
|
Cytosol | 2 | 2001 | 47 | 0.230 |
Why?
|
Receptors, CXCR4 | 1 | 2024 | 27 | 0.230 |
Why?
|
Antigens, CD1d | 4 | 2016 | 45 | 0.220 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2023 | 7 | 0.220 |
Why?
|
Mutagenesis, Insertional | 3 | 2008 | 37 | 0.220 |
Why?
|
Immunity, Humoral | 3 | 2020 | 46 | 0.220 |
Why?
|
Neutralization Tests | 7 | 2020 | 32 | 0.220 |
Why?
|
Vaccination | 3 | 2021 | 167 | 0.220 |
Why?
|
Gene Expression | 4 | 2013 | 406 | 0.210 |
Why?
|
Antibody Specificity | 3 | 2020 | 113 | 0.210 |
Why?
|
Epiphyses | 1 | 2022 | 1 | 0.210 |
Why?
|
Respiratory Tract Infections | 2 | 2013 | 35 | 0.210 |
Why?
|
Glycogen Synthase Kinase 3 beta | 3 | 2008 | 40 | 0.210 |
Why?
|
Geologic Sediments | 3 | 2007 | 67 | 0.200 |
Why?
|
Radiography | 1 | 2022 | 200 | 0.200 |
Why?
|
Alum Compounds | 1 | 2022 | 6 | 0.200 |
Why?
|
Quorum Sensing | 1 | 2021 | 5 | 0.200 |
Why?
|
Polysaccharides, Bacterial | 1 | 2021 | 13 | 0.190 |
Why?
|
Ovalbumin | 2 | 1998 | 7 | 0.190 |
Why?
|
Digestive System | 1 | 2021 | 16 | 0.190 |
Why?
|
Receptors, Fc | 1 | 2021 | 30 | 0.190 |
Why?
|
Leukocytes, Mononuclear | 2 | 2018 | 73 | 0.190 |
Why?
|
Membrane Proteins | 2 | 2023 | 466 | 0.180 |
Why?
|
Peptides | 2 | 2021 | 280 | 0.180 |
Why?
|
Disease Susceptibility | 1 | 2021 | 72 | 0.180 |
Why?
|
Civil Defense | 1 | 2020 | 2 | 0.180 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 64 | 0.180 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2018 | 130 | 0.180 |
Why?
|
CRISPR-Cas Systems | 1 | 2020 | 43 | 0.180 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 324 | 0.180 |
Why?
|
Skin Diseases, Bacterial | 1 | 2020 | 9 | 0.180 |
Why?
|
Antitoxins | 2 | 2021 | 13 | 0.170 |
Why?
|
Movement | 1 | 2020 | 92 | 0.170 |
Why?
|
Protein Binding | 3 | 2013 | 631 | 0.170 |
Why?
|
Betacoronavirus | 1 | 2020 | 37 | 0.170 |
Why?
|
Recombinant Proteins | 5 | 2011 | 408 | 0.170 |
Why?
|
Protein Structure, Tertiary | 4 | 2015 | 283 | 0.170 |
Why?
|
Coronavirus Infections | 1 | 2020 | 47 | 0.170 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 51 | 0.170 |
Why?
|
Biomedical Research | 1 | 2020 | 93 | 0.170 |
Why?
|
Sequence Deletion | 1 | 2019 | 65 | 0.170 |
Why?
|
Protein Domains | 1 | 2019 | 48 | 0.160 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2009 | 24 | 0.160 |
Why?
|
Plasma Cells | 1 | 2019 | 21 | 0.160 |
Why?
|
Depsipeptides | 1 | 2018 | 5 | 0.160 |
Why?
|
Pandemics | 1 | 2020 | 166 | 0.160 |
Why?
|
Endopeptidase Clp | 1 | 2018 | 9 | 0.160 |
Why?
|
RAW 264.7 Cells | 1 | 2018 | 21 | 0.160 |
Why?
|
B-Lymphocyte Subsets | 1 | 2019 | 30 | 0.160 |
Why?
|
Immunomodulation | 1 | 2018 | 19 | 0.160 |
Why?
|
Phagocytosis | 2 | 2010 | 78 | 0.160 |
Why?
|
Anti-Bacterial Agents | 5 | 2013 | 496 | 0.160 |
Why?
|
Phylogeny | 1 | 2020 | 461 | 0.150 |
Why?
|
Immunoconjugates | 1 | 1998 | 17 | 0.150 |
Why?
|
Molecular Weight | 2 | 2011 | 118 | 0.150 |
Why?
|
Amiloride | 1 | 2017 | 3 | 0.150 |
Why?
|
Pinocytosis | 1 | 2017 | 17 | 0.150 |
Why?
|
Host-Pathogen Interactions | 3 | 2019 | 89 | 0.150 |
Why?
|
Inflammation Mediators | 1 | 2018 | 152 | 0.140 |
Why?
|
Blotting, Western | 2 | 2009 | 503 | 0.140 |
Why?
|
Desulfovibrio desulfuricans | 2 | 2007 | 9 | 0.140 |
Why?
|
Proteolysis | 2 | 2018 | 55 | 0.140 |
Why?
|
Shewanella | 2 | 2006 | 9 | 0.130 |
Why?
|
Cell Differentiation | 1 | 2019 | 395 | 0.130 |
Why?
|
Interleukin-4 | 2 | 2016 | 23 | 0.130 |
Why?
|
Cross Reactions | 2 | 2013 | 65 | 0.130 |
Why?
|
Retrospective Studies | 1 | 2022 | 2433 | 0.130 |
Why?
|
Epitope Mapping | 2 | 2013 | 38 | 0.130 |
Why?
|
Cardiotoxicity | 1 | 2015 | 4 | 0.130 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 2015 | 23 | 0.120 |
Why?
|
Disease Models, Animal | 3 | 2022 | 1394 | 0.120 |
Why?
|
Adult | 7 | 2020 | 7384 | 0.120 |
Why?
|
Lymphocyte Activation | 3 | 2022 | 204 | 0.120 |
Why?
|
Transfection | 2 | 2008 | 312 | 0.120 |
Why?
|
Caspase Inhibitors | 2 | 2006 | 8 | 0.120 |
Why?
|
Sequence Alignment | 1 | 2015 | 110 | 0.120 |
Why?
|
Flow Cytometry | 3 | 2010 | 282 | 0.120 |
Why?
|
Middle Aged | 6 | 2020 | 6820 | 0.120 |
Why?
|
Enzyme Activation | 2 | 2007 | 262 | 0.120 |
Why?
|
DNA, Bacterial | 5 | 2007 | 301 | 0.120 |
Why?
|
Base Sequence | 4 | 2006 | 573 | 0.110 |
Why?
|
Young Adult | 3 | 2020 | 2582 | 0.110 |
Why?
|
Desulfovibrio vulgaris | 2 | 2004 | 17 | 0.110 |
Why?
|
Erythrocyte Membrane | 1 | 1993 | 22 | 0.110 |
Why?
|
Enzyme Inhibitors | 2 | 2008 | 247 | 0.110 |
Why?
|
Antibodies | 2 | 2011 | 124 | 0.110 |
Why?
|
Hemolysin Proteins | 1 | 1993 | 53 | 0.110 |
Why?
|
Co-Repressor Proteins | 1 | 2013 | 8 | 0.110 |
Why?
|
Bucladesine | 1 | 2013 | 11 | 0.110 |
Why?
|
Transcription Factor HES-1 | 1 | 2013 | 6 | 0.110 |
Why?
|
Luciferases | 1 | 2013 | 49 | 0.110 |
Why?
|
Fluorescent Dyes | 2 | 2006 | 88 | 0.110 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 1263 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 47 | 0.110 |
Why?
|
Immunoblotting | 1 | 2013 | 122 | 0.110 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 74 | 0.100 |
Why?
|
MAP Kinase Signaling System | 2 | 2003 | 93 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2013 | 173 | 0.100 |
Why?
|
Alveolar Epithelial Cells | 1 | 2012 | 14 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 3 | 2003 | 228 | 0.100 |
Why?
|
Sepsis | 1 | 2013 | 81 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2009 | 129 | 0.100 |
Why?
|
Phytic Acid | 1 | 2012 | 4 | 0.100 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 152 | 0.100 |
Why?
|
Serum Amyloid A Protein | 1 | 2011 | 2 | 0.100 |
Why?
|
Antibodies, Monoclonal | 3 | 2021 | 316 | 0.100 |
Why?
|
Chlorides | 1 | 2011 | 13 | 0.100 |
Why?
|
Sulfur Compounds | 1 | 2011 | 3 | 0.100 |
Why?
|
Colony Count, Microbial | 2 | 2008 | 78 | 0.100 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2011 | 5 | 0.100 |
Why?
|
Osmolar Concentration | 1 | 2011 | 25 | 0.100 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 42 | 0.100 |
Why?
|
Protein Transport | 1 | 2012 | 152 | 0.100 |
Why?
|
DNA Transposable Elements | 2 | 2008 | 33 | 0.090 |
Why?
|
Transcription, Genetic | 2 | 2011 | 400 | 0.090 |
Why?
|
Genes, Reporter | 1 | 2011 | 88 | 0.090 |
Why?
|
Chemokines | 1 | 2011 | 73 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 36 | 0.090 |
Why?
|
Threonine | 1 | 2011 | 21 | 0.090 |
Why?
|
Mutant Proteins | 1 | 2011 | 25 | 0.090 |
Why?
|
Male | 9 | 2021 | 12874 | 0.090 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2009 | 75 | 0.090 |
Why?
|
Serine | 1 | 2011 | 48 | 0.090 |
Why?
|
Interferon-gamma | 1 | 2011 | 102 | 0.090 |
Why?
|
Gene Silencing | 1 | 2011 | 63 | 0.090 |
Why?
|
Cell Survival | 2 | 2011 | 394 | 0.090 |
Why?
|
Stereoisomerism | 2 | 2007 | 45 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 90 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2011 | 67 | 0.090 |
Why?
|
Cell Separation | 1 | 2010 | 55 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 1 | 2011 | 100 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2011 | 782 | 0.090 |
Why?
|
Antibody Formation | 3 | 2024 | 75 | 0.090 |
Why?
|
Myelin Basic Protein | 1 | 2009 | 4 | 0.090 |
Why?
|
Phosphopeptides | 1 | 2009 | 11 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 113 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 333 | 0.080 |
Why?
|
Lysosomes | 1 | 2010 | 54 | 0.080 |
Why?
|
Macrophages, Alveolar | 1 | 2009 | 35 | 0.080 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 165 | 0.080 |
Why?
|
Gene Order | 1 | 2008 | 9 | 0.080 |
Why?
|
Nisin | 1 | 2008 | 2 | 0.080 |
Why?
|
Incidence | 1 | 2010 | 545 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2009 | 186 | 0.080 |
Why?
|
Cell Death | 2 | 2011 | 110 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 110 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2008 | 32 | 0.080 |
Why?
|
Copper | 2 | 2004 | 44 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 110 | 0.080 |
Why?
|
beta Catenin | 1 | 2008 | 62 | 0.080 |
Why?
|
T-Lymphocytes | 1 | 2010 | 274 | 0.080 |
Why?
|
Dimerization | 2 | 2007 | 75 | 0.080 |
Why?
|
Alanine Racemase | 1 | 2007 | 2 | 0.070 |
Why?
|
Glucosyltransferases | 1 | 2007 | 3 | 0.070 |
Why?
|
Mice, Inbred DBA | 1 | 2007 | 30 | 0.070 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2007 | 11 | 0.070 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2007 | 22 | 0.070 |
Why?
|
bcl-X Protein | 1 | 2007 | 34 | 0.070 |
Why?
|
Amino Acid Isomerases | 1 | 2007 | 1 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2007 | 72 | 0.070 |
Why?
|
Genes, MDR | 1 | 2006 | 5 | 0.070 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2006 | 23 | 0.070 |
Why?
|
Protein Structure, Quaternary | 1 | 2006 | 26 | 0.070 |
Why?
|
Transduction, Genetic | 1 | 2006 | 24 | 0.070 |
Why?
|
Lethal Dose 50 | 1 | 2006 | 13 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2007 | 148 | 0.070 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 44 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2006 | 59 | 0.070 |
Why?
|
Endosomes | 1 | 2006 | 44 | 0.070 |
Why?
|
Myocardium | 1 | 2007 | 171 | 0.070 |
Why?
|
Species Specificity | 1 | 2006 | 186 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 253 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2003 | 262 | 0.060 |
Why?
|
Air Sacs | 1 | 2005 | 2 | 0.060 |
Why?
|
Rats | 2 | 2006 | 1545 | 0.060 |
Why?
|
Swiss 3T3 Cells | 1 | 2005 | 2 | 0.060 |
Why?
|
Skull | 1 | 2005 | 36 | 0.060 |
Why?
|
Necrosis | 1 | 2005 | 81 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 190 | 0.060 |
Why?
|
Gastrointestinal Tract | 1 | 2005 | 34 | 0.060 |
Why?
|
Genotype | 1 | 2006 | 443 | 0.060 |
Why?
|
Cholesterol | 1 | 2006 | 182 | 0.060 |
Why?
|
Heart Rate | 1 | 2006 | 374 | 0.060 |
Why?
|
Ecosystem | 1 | 2006 | 205 | 0.060 |
Why?
|
Chemokine CXCL12 | 1 | 2024 | 9 | 0.060 |
Why?
|
Endopeptidases | 1 | 2004 | 20 | 0.060 |
Why?
|
Glycosyltransferases | 1 | 2004 | 31 | 0.060 |
Why?
|
Mercury | 1 | 2004 | 12 | 0.060 |
Why?
|
Isoenzymes | 2 | 2018 | 86 | 0.060 |
Why?
|
Cysteine Endopeptidases | 1 | 2003 | 17 | 0.060 |
Why?
|
Multienzyme Complexes | 1 | 2003 | 29 | 0.060 |
Why?
|
Ubiquitin | 1 | 2003 | 24 | 0.060 |
Why?
|
Molecular Motor Proteins | 1 | 2003 | 12 | 0.060 |
Why?
|
Tubulin | 1 | 2003 | 30 | 0.050 |
Why?
|
Drug Resistance | 1 | 2003 | 42 | 0.050 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2003 | 80 | 0.050 |
Why?
|
Cell Cycle | 1 | 2003 | 155 | 0.050 |
Why?
|
Liver | 1 | 2005 | 415 | 0.050 |
Why?
|
Vimentin | 1 | 2002 | 26 | 0.050 |
Why?
|
Caspase 3 | 1 | 2002 | 56 | 0.050 |
Why?
|
Lactates | 1 | 2002 | 18 | 0.050 |
Why?
|
Survival Analysis | 2 | 2015 | 276 | 0.050 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2022 | 13 | 0.050 |
Why?
|
Desulfovibrio | 1 | 2002 | 20 | 0.050 |
Why?
|
Bortezomib | 1 | 2021 | 18 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2022 | 58 | 0.050 |
Why?
|
Hydrogen | 1 | 2002 | 56 | 0.050 |
Why?
|
Gene Editing | 1 | 2021 | 18 | 0.050 |
Why?
|
Sulfates | 1 | 2002 | 86 | 0.050 |
Why?
|
Lymphocytes | 1 | 2022 | 83 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2021 | 117 | 0.050 |
Why?
|
Ligands | 1 | 2022 | 168 | 0.050 |
Why?
|
Immunity | 1 | 2021 | 26 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 2001 | 19 | 0.050 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 15 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2001 | 149 | 0.040 |
Why?
|
Naphthalenesulfonates | 1 | 2000 | 1 | 0.040 |
Why?
|
Proton-Translocating ATPases | 1 | 2000 | 7 | 0.040 |
Why?
|
Turkey | 1 | 2020 | 9 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2000 | 18 | 0.040 |
Why?
|
Tryptophan | 1 | 2000 | 39 | 0.040 |
Why?
|
Mucous Membrane | 1 | 2020 | 26 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2020 | 22 | 0.040 |
Why?
|
Universities | 1 | 2020 | 115 | 0.040 |
Why?
|
Public Health | 1 | 2020 | 84 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 1999 | 6 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1999 | 26 | 0.040 |
Why?
|
Antigens, Viral | 1 | 1999 | 23 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 233 | 0.040 |
Why?
|
CD4 Antigens | 1 | 1998 | 18 | 0.040 |
Why?
|
H-2 Antigens | 1 | 1998 | 14 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2003 | 364 | 0.040 |
Why?
|
Antigens | 1 | 2019 | 66 | 0.040 |
Why?
|
Escherichia coli | 2 | 2007 | 328 | 0.040 |
Why?
|
Disulfides | 1 | 1998 | 33 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2020 | 702 | 0.040 |
Why?
|
Biomarkers | 1 | 2022 | 733 | 0.040 |
Why?
|
Cysteine | 1 | 1998 | 67 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 106 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 1998 | 131 | 0.040 |
Why?
|
Immunotherapy, Adoptive | 1 | 1998 | 15 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1998 | 100 | 0.040 |
Why?
|
Inflammation | 1 | 2022 | 601 | 0.040 |
Why?
|
Culture Media | 2 | 2008 | 97 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 2 | 2008 | 135 | 0.040 |
Why?
|
Proteomics | 1 | 2018 | 177 | 0.040 |
Why?
|
Cross-Priming | 1 | 2016 | 5 | 0.030 |
Why?
|
Haptens | 1 | 2016 | 8 | 0.030 |
Why?
|
Listeria monocytogenes | 1 | 1996 | 58 | 0.030 |
Why?
|
Proteins | 1 | 1998 | 244 | 0.030 |
Why?
|
Hemolysis | 2 | 1994 | 46 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 20 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 25 | 0.030 |
Why?
|
Interleukins | 1 | 2016 | 108 | 0.030 |
Why?
|
Troponin I | 1 | 2015 | 14 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 1928 | 0.030 |
Why?
|
Aeromonas hydrophila | 1 | 1995 | 2 | 0.030 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 1995 | 13 | 0.030 |
Why?
|
Type C Phospholipases | 1 | 1994 | 31 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1995 | 205 | 0.030 |
Why?
|
United States | 1 | 2020 | 2032 | 0.030 |
Why?
|
Models, Biological | 1 | 1996 | 446 | 0.030 |
Why?
|
Models, Molecular | 2 | 2007 | 441 | 0.030 |
Why?
|
Trypsin | 1 | 1993 | 24 | 0.030 |
Why?
|
Potassium | 1 | 1993 | 41 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 1993 | 42 | 0.030 |
Why?
|
Viper Venoms | 1 | 2013 | 5 | 0.030 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2013 | 16 | 0.030 |
Why?
|
Gram-Positive Bacteria | 1 | 2013 | 33 | 0.030 |
Why?
|
Immune System | 1 | 2013 | 29 | 0.030 |
Why?
|
RNA, Bacterial | 2 | 2004 | 65 | 0.030 |
Why?
|
Aged | 2 | 2020 | 5168 | 0.030 |
Why?
|
Mixed Function Oxygenases | 1 | 2012 | 19 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2012 | 60 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2012 | 50 | 0.030 |
Why?
|
Actins | 1 | 2012 | 93 | 0.030 |
Why?
|
Guinea Pigs | 1 | 1992 | 73 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 45 | 0.020 |
Why?
|
Th2 Cells | 1 | 2011 | 14 | 0.020 |
Why?
|
Protective Agents | 1 | 2011 | 17 | 0.020 |
Why?
|
Rabbits | 1 | 1992 | 272 | 0.020 |
Why?
|
Glycolipids | 1 | 2011 | 18 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2011 | 17 | 0.020 |
Why?
|
Bioterrorism | 1 | 2010 | 28 | 0.020 |
Why?
|
Blood | 1 | 2010 | 33 | 0.020 |
Why?
|
Penicillamine | 1 | 1990 | 9 | 0.020 |
Why?
|
Biotin | 1 | 1990 | 25 | 0.020 |
Why?
|
Sheep | 1 | 2010 | 97 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2009 | 7 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2010 | 62 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 2008 | 14 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2008 | 61 | 0.020 |
Why?
|
African Americans | 1 | 2011 | 350 | 0.020 |
Why?
|
Succinimides | 1 | 2008 | 6 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 80 | 0.020 |
Why?
|
Structural Homology, Protein | 1 | 2007 | 8 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 161 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2007 | 36 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2007 | 50 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2007 | 130 | 0.020 |
Why?
|
Chloramphenicol | 1 | 2006 | 6 | 0.020 |
Why?
|
Oklahoma | 1 | 2010 | 973 | 0.020 |
Why?
|
Operon | 1 | 2006 | 40 | 0.020 |
Why?
|
Binding Sites | 1 | 2007 | 338 | 0.020 |
Why?
|
Anaerobiosis | 1 | 2005 | 90 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2005 | 27 | 0.020 |
Why?
|
Plasmids | 1 | 2005 | 121 | 0.020 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 2004 | 4 | 0.010 |
Why?
|
Peptide Mapping | 1 | 2003 | 22 | 0.010 |
Why?
|
Mutagenesis | 1 | 2003 | 45 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2003 | 30 | 0.010 |
Why?
|
RNA, Ribosomal | 1 | 2003 | 51 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 2003 | 167 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2005 | 439 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 143 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 46 | 0.010 |
Why?
|
Sulfides | 1 | 2002 | 38 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2002 | 354 | 0.010 |
Why?
|
Virus Diseases | 1 | 1999 | 38 | 0.010 |
Why?
|
Antigen Presentation | 1 | 1999 | 78 | 0.010 |
Why?
|
Antiviral Agents | 1 | 1999 | 104 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1998 | 58 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1998 | 61 | 0.010 |
Why?
|
Immunotherapy | 1 | 1999 | 135 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1998 | 163 | 0.010 |
Why?
|
Gas Gangrene | 1 | 1994 | 3 | 0.010 |
Why?
|
Immunocompetence | 1 | 1994 | 6 | 0.010 |
Why?
|
Aziridines | 1 | 1990 | 2 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 1990 | 22 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1990 | 42 | 0.010 |
Why?
|
Serum Albumin | 1 | 1990 | 35 | 0.010 |
Why?
|
Drug Carriers | 1 | 1990 | 109 | 0.000 |
Why?
|
Kinetics | 1 | 1990 | 538 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1990 | 802 | 0.000 |
Why?
|